Replies to post #86219 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

This is illogical
If it were a surge at one yearAnavex would not have dropped Dual Therapy as a Strata ! It is a change to monotherapy.

[seventhwave]

The different between 52 weeks and 57 weeks - the surge - is it result of dropping DZP or indication of sudden onset of A2-73 efficacy?

Could the difference be the result of 5 poor responders (on dual therapy?) dropping out of the study at the end of 52 weeks (n dropping from 30 to 25) making the remaining pool of 25 LOOK LIKE they improved?
Or do ALL POINTS in data series up to 57 weeks NOW represent n=25?

blu, mcmag, frrol, basparks, anyone?

[Maple tree]

Could be due to drop of DZP. If I remember correctly, a small group of patients with 273 treatment alone at 31 weeks did better than other patients with both DZP and 273.
Happy New Year and Wish 2017 a Bright Year for AVXL